Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles were propelled into the global spotlight for their role in two approved COVID mRNA vaccines. However, lipid nanoparticles aren't unique, in fact their development started decades ago as liposomes and as critical drug delivery vehicles. Only now, has more and more opportunities for advancement and applications emerged.

Lipid Nanoparticles white paper cover

{{lipid="/ads"}}

Download the CAS Insights Report

Related CAS Insights

製薬分野の特許の状勢に関するCAS Insightsウェビナーのハイライト

免疫腫瘍学における新しいトランスレーショナルリサーチは、現在の治療法に反応しない患者に届く可能性があります。

CAS Insightsレポート:特許インテリジェンスを通じて製薬イノベーションの未来を切り拓く。

Gain new perspectives for faster progress directly to your inbox.